Engineered albumin-fused FIX extends hemophilia B treatment half-life beyond standard 3–4 day window

After blood vessel damage, effective blood clotting is essential to halt bleeding. However, this process is inefficient in some individuals due to hereditary factors. Hemophilia B, for example, results from a deficiency in coagulation factor IX (FIX), which can lead to prolonged bleeding after injuries or surgery.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup